CD44 and breast carcinoma: Reflecting these results, when we checked the CSC contents of different breast cancer cell lines, we obtained higher percent of (CD44+/CD24−) CSCs in TNBC cell lines, i.e., MDA-MB-468 and MDA-MB-231, as compared to luminal MCF-7 cell line (Fig. 1F).